CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Vistin Pharma ASA Company Snapshot
Vistin Pharma ASA operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vistin Pharma ASA with three other companies in this sector in NORWAY : Photocure ASA (2019 sales of 281.56 million Norwegian Kroner [US$30.96 million] of which 52% was Hexvix/Cysview Own Sales), Nattopharma ASA (127.12 million Norwegian Kroner [US$13.98 million] of which 100% was Vitamin K2/MenaQ7), and Norda ASA (83.94 million Norwegian Kroner [US$9.23 million] ).

Sales Analysis. During the year ended December of 2019, sales at Vistin Pharma ASA were NOK 227.19 million (US$24.98 million). This is an increase of 14.2% versus 2018, when the company's sales were NOK 198.99 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Vistin Pharma ASA
  Stock Performance Chart for Vistin Pharma ASA
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 18.10
(Figures in Norwegian Kroner)
1 Week -5.0%   13 Weeks 24.0%  
4 Weeks 42.5%   52 Weeks 101.1%  
 
Vistin Pharma ASA Key Data:
  Ticker: VISTIN Country: Norway
  Exchanges: OSL Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 227,186,000
(Year Ending Jan 2020).
Employees: 74
  Currency: Norwegian Kroner Market Cap: 802,637,115
  Fiscal Yr Ends: December Shares Outstanding: 44,344,592
  Share Type: Ordinary Closely Held Shares: 16,258,356
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.